EPIDERMAL GROWTH FACTOR

Clinical trials for EPIDERMAL GROWTH FACTOR explained in plain language.

Never miss a new study

Get alerted when new EPIDERMAL GROWTH FACTOR trials appear

Sign up with your email to follow new studies for EPIDERMAL GROWTH FACTOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

First patients to receive new cancer drug in groundbreaking safety trial

Disease control Recruiting now

This is the first-ever study in people for a new drug called EPI-326. It aims to find a safe dose and see how the body handles the drug in patients with advanced lung cancer (with a specific genetic change called EGFR mutation) or advanced head and neck cancer. The main goal is t…

Matched conditions: EPIDERMAL GROWTH FACTOR

Phase: PHASE1 • Sponsor: EpiBiologics • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

EPIDERMAL GROWTH FACTOR

Get alerted when new EPIDERMAL GROWTH FACTOR trials appear

First patients to receive new cancer drug in groundbreaking safety trial